FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016207968> ?p ?o ?g. }

• W2016207968 endingPage "914" @default.
• W2016207968 startingPage "906" @default.
• W2016207968 abstract "Tumor necrosis factor-alpha (TNF-alpha) and angiotensin II (Ang II) induced a transient increase in vascular smooth muscle cell (VSMC) cyclooxygenase-2 (COX-2) mRNA accumulation, without affecting COX-1 mRNA levels. The kinetics of COX-2 mRNA accumulation were similar in VSMCs challenged with either TNF-alpha or Ang II; mRNA accumulation peaked at 2 hours and decreased to control levels by approximately 6 hours. Accumulation of COX-2 mRNA was associated with a time-dependent increase of COX-2 protein expression that displayed similar kinetics in response to either TNF-alpha or Ang II. Both the increase in COX-2 mRNA accumulation and protein expression in response to either TNF-alpha or Ang II were inhibited by the mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitor PD098059. In addition, the AT(1)-selective receptor antagonist losartan attenuated the Ang II-mediated increase in COX-2 mRNA accumulation; the AT(2)-selective antagonist PD123319 had no effect. Prostacyclin I(2) synthesis was tightly coupled to expression of COX-2, whereas prostaglandin E(2) and thromboxane A(2) (TXA(2)) synthesis may be associated with differential usage of COX-1 and COX-2. The COX-2-selective inhibitors NS-398 and nimesulide and the TXA(2) receptor antagonist BMS 180,291 inhibited TNF-alpha- and Ang II-mediated increases in DNA content and cell number by approximately 95%. These findings suggest that a prostanoid derived from COX-2, possibly TXA(2), may contribute to VSMC hyperplasia in vessel injury or pathophysiological conditions associated with elevated levels of either TNF-alpha or Ang II." @default.
• W2016207968 created "2016-06-24" @default.
• W2016207968 creator A5007408600 @default.
• W2016207968 creator A5020516086 @default.
• W2016207968 creator A5054045914 @default.
• W2016207968 creator A5055910048 @default.
• W2016207968 creator A5080825662 @default.
• W2016207968 date "2000-04-28" @default.
• W2016207968 modified "2023-09-27" @default.
• W2016207968 title "Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-α– and Angiotensin II–Mediated Proliferation of Vascular Smooth Muscle Cells" @default.
• W2016207968 cites W1496561250 @default.
• W2016207968 cites W1587059515 @default.
• W2016207968 cites W1970061904 @default.
• W2016207968 cites W1991189527 @default.
• W2016207968 cites W2020563114 @default.
• W2016207968 cites W2034679499 @default.
• W2016207968 cites W2037817605 @default.
• W2016207968 cites W2057620757 @default.
• W2016207968 cites W2063014011 @default.
• W2016207968 cites W2076092023 @default.
• W2016207968 cites W2086085366 @default.
• W2016207968 cites W2149482537 @default.
• W2016207968 cites W2152113795 @default.
• W2016207968 cites W2176899369 @default.
• W2016207968 cites W2187699488 @default.
• W2016207968 cites W2335557853 @default.
• W2016207968 cites W2403849098 @default.
• W2016207968 doi "https://doi.org/10.1161/01.res.86.8.906" @default.
• W2016207968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10785514" @default.
• W2016207968 hasPublicationYear "2000" @default.
• W2016207968 type Work @default.
• W2016207968 sameAs 2016207968 @default.
• W2016207968 citedByCount "66" @default.
• W2016207968 countsByYear W20162079682012 @default.
• W2016207968 countsByYear W20162079682013 @default.
• W2016207968 countsByYear W20162079682014 @default.
• W2016207968 countsByYear W20162079682015 @default.
• W2016207968 countsByYear W20162079682016 @default.
• W2016207968 countsByYear W20162079682017 @default.
• W2016207968 countsByYear W20162079682018 @default.
• W2016207968 countsByYear W20162079682019 @default.
• W2016207968 countsByYear W20162079682020 @default.
• W2016207968 countsByYear W20162079682021 @default.
• W2016207968 countsByYear W20162079682022 @default.
• W2016207968 crossrefType "journal-article" @default.
• W2016207968 hasAuthorship W2016207968A5007408600 @default.
• W2016207968 hasAuthorship W2016207968A5020516086 @default.
• W2016207968 hasAuthorship W2016207968A5054045914 @default.
• W2016207968 hasAuthorship W2016207968A5055910048 @default.
• W2016207968 hasAuthorship W2016207968A5080825662 @default.
• W2016207968 hasBestOaLocation W20162079681 @default.
• W2016207968 hasConcept C126322002 @default.
• W2016207968 hasConcept C134018914 @default.
• W2016207968 hasConcept C170493617 @default.
• W2016207968 hasConcept C17991360 @default.
• W2016207968 hasConcept C181199279 @default.
• W2016207968 hasConcept C185592680 @default.
• W2016207968 hasConcept C2776885963 @default.
• W2016207968 hasConcept C2778122271 @default.
• W2016207968 hasConcept C2779395532 @default.
• W2016207968 hasConcept C2779689624 @default.
• W2016207968 hasConcept C2780288358 @default.
• W2016207968 hasConcept C2908929049 @default.
• W2016207968 hasConcept C2992686903 @default.
• W2016207968 hasConcept C55493867 @default.
• W2016207968 hasConcept C71924100 @default.
• W2016207968 hasConcept C86803240 @default.
• W2016207968 hasConceptScore W2016207968C126322002 @default.
• W2016207968 hasConceptScore W2016207968C134018914 @default.
• W2016207968 hasConceptScore W2016207968C170493617 @default.
• W2016207968 hasConceptScore W2016207968C17991360 @default.
• W2016207968 hasConceptScore W2016207968C181199279 @default.
• W2016207968 hasConceptScore W2016207968C185592680 @default.
• W2016207968 hasConceptScore W2016207968C2776885963 @default.
• W2016207968 hasConceptScore W2016207968C2778122271 @default.
• W2016207968 hasConceptScore W2016207968C2779395532 @default.
• W2016207968 hasConceptScore W2016207968C2779689624 @default.
• W2016207968 hasConceptScore W2016207968C2780288358 @default.
• W2016207968 hasConceptScore W2016207968C2908929049 @default.
• W2016207968 hasConceptScore W2016207968C2992686903 @default.
• W2016207968 hasConceptScore W2016207968C55493867 @default.
• W2016207968 hasConceptScore W2016207968C71924100 @default.
• W2016207968 hasConceptScore W2016207968C86803240 @default.
• W2016207968 hasIssue "8" @default.
• W2016207968 hasLocation W20162079681 @default.
• W2016207968 hasLocation W20162079682 @default.
• W2016207968 hasOpenAccess W2016207968 @default.
• W2016207968 hasPrimaryLocation W20162079681 @default.
• W2016207968 hasRelatedWork W1974596937 @default.
• W2016207968 hasRelatedWork W1991369276 @default.
• W2016207968 hasRelatedWork W1992425802 @default.
• W2016207968 hasRelatedWork W2027470168 @default.
• W2016207968 hasRelatedWork W2043032068 @default.
• W2016207968 hasRelatedWork W2091193686 @default.
• W2016207968 hasRelatedWork W2101909726 @default.
• W2016207968 hasRelatedWork W2316210001 @default.
• W2016207968 hasRelatedWork W2339854003 @default.
• W2016207968 hasRelatedWork W3173404325 @default.

• next